I acknowledge that the news regarding the 20 virus govt research of B is quite promising, the Squamus investment could be quite promising, the Kips Bay additional investment is certainly a bit of news that looks promising, the government stating that they need to find a COVID drug that is safe, works against not only viruses but infections as well is positive, the Marburg filovirus spread is quite scary but B has been shown to be effective in initial lab testing per PR LAST YEAR (yet nothing has been done since then to prepare exactly for what is happening today and killing people, possibly in great numbers soon?), the hiring of a BP deal maker appears extremely positive as Leo has shown no aptitude whatsoever tin getting a deal signed for any part of our drug platforms, and the upcoming presentation in Sept appears positive.
I am not questioning that things appear to be coming together in a far, far, far better manner than what seemed to be happening in the first 5 months of the year.
But, it appeared that B was in a perfect storm for success when we started our Covid trial and only later did we find out the FDA tanked our trial with a low dosage, minimal dosing requirement, B was given far too late in the life cycle of Covid to provide any benefit, Russia tested mainly patients way more severe than the trial was supposed to test, and most patients were taking other drugs that were supposed to have kept them out of the trial as they worked against B effectiveness.
I point out the above to show that the value of our positive sounding items above all lay in the details and the details will determine whether they will come to fruition.
I don't mean to scare any new eyes coming to IPIX, our science to date looks extremely promising but we have been saying that now for about 7 years and this investment has mainly brought most of us to our knees financially.
IPIX is still under the thumb of the hedge funds and they ALONE control our stock price. They could tomorrow take it to $.25 or bring it down to $.015 without the bat of an eye. So trying to find technical reasons for our stock rise IMO is foolish.
IPIX isn't dead, but it has a hell of a ways to go to return to good health. I reiterate my point since last November with the terrible price dive, IPIX will not be anywhere near healthy UNTIL we sign some sort of deal that brings in significant funds or we get a major government grant that does the same. At this time, I believe a sale or partnership of some part of our drug platforms is the best shot we have to climb out of the grave we are currently in.
Being somewhat positive is to be expected and that reflects my view of IPIX today, but don't think this is a slam dunk winner yet by any means.
